DNA methylation in development and human disease

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 647, Issue 1-2, 2008, Pages 30-38

  Gopalakrishnan, Suhasni ^a   Van Emburgh, Beth O ^a   Robertson, Keith D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cancer; Chromatin; DNA methyltransferase; Gene regulation; Histone modifications; ICF syndrome; Polycomb

Indexed keywords

DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EZH2 PROTEIN; HISTONE; HISTONE H3 LYSINE 9; HISTONE METHYLTRANSFERASE; POLYCOMB GROUP PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL RENEWAL; CPG ISLAND; DNA HYPERMETHYLATION; DNA HYPOMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE SILENCING; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; IMMUNODEFICIENCY CENTROMERIC INSTABILITY FACIAL ANOMALY SYNDROME; NEOPLASM; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; CELL DIFFERENTIATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GROWTH AND DEVELOPMENT; HUMANS; MODELS, GENETIC; NEOPLASMS; PLURIPOTENT STEM CELLS; REPRESSOR PROTEINS;

EID: 56149116270     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.08.006     Document Type: Review

References (77)

1. Goll M.G., and Bestor T.H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74 (2005) 481-514
2. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.M., Bollen M., Esteller M., Di Croce L., de Launoit Y., and Fuks F. The polycomb group protein EZH2 directly controls DNA methylation. Nature 439 (2006) 871-874
3. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3 (2002) 662-673
4. Suetake I., Shinozaki F., Miyagawa J., Takeshima H., and Tajima S. DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J. Biol. Chem. 279 (2004) 27816-27823
5. Watanabe D., Suetake I., Tada T., and Tajima S. Stage- and cell-specific expression of Dnmt3a and Dnmt3b during embryogenesis. Mech. Dev. 118 (2002) 187-190
6. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., Wong K.Y., Sung K.W., Lee C.W., Zhao X.D., Chiu K.P., Lipovich L., Kuznetsov V.A., Robson P., Stanton L.W., Wei C.L., Ruan Y., Lim B., and Ng H.H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38 (2006) 431-440
7. Hattori N., Nishino K., Ko Y.G., Hattori N., Ohgane J., Tanaka S., and Shiota K. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 279 (2004) 17063-17069
8. Fuhrmann G., Chung A.C., Jackson K.J., Hummelke G., Baniahmad A., Sutter J., Sylvester I., Scholer H.R., and Cooney A.J. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev. Cell. 1 (2001) 377-387
9. Feldman N., Gerson A., Fang J., Li E., Zhang Y., Shinkai Y., Cedar H., and Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell. Biol. 8 (2006) 188-194
10. Gu P., Le Menuet D., Chung A.C., and Cooney A.J. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression. Mol. Cell. Biol. 26 (2006) 9471-9483
11. Li J.Y., Pu M.T., Hirasawa R., Li B.Z., Huang Y.N., Zeng R., Jing N.H., Chen T., Li E., Sasaki H., and Xu G.L. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol. Cell. Biol. 27 (2007) 8748-8759
12. Simonsson S., and Gurdon J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell. Biol. 6 (2004) 984-990
13. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
14. Boiani M., Eckardt S., Scholer H.R., and McLaughlin K.J. Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev. 16 (2002) 1209-1219
15. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., Bergman Y., Simon I., and Cedar H. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet. 39 (2007) 232-236
16. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., Weisenberger D.J., Campan M., Young J., Jacobs I., and Laird P.W. Epigenetic stem cell signature in cancer. Nat. Genet. 39 (2007) 157-158
17. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M., and Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39 (2007) 457-466
18. Jia D., Jurkowska R.Z., Zhang X., Jeltsch A., and Cheng X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 449 (2007) 248-251
19. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., Cheng X., and Bestor T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448 (2007) 714-717
20. Bushati N., and Cohen S.M. microRNA functions. Annu. Rev. Cell. Dev. Biol. 23 (2007) 175-205
21. Benetti R., Gonzalo S., Jaco I., Munoz P., Gonzalez S., Schoeftner S., Murchison E., Andl T., Chen T., Klatt P., Li E., Serrano M., Millar S., Hannon G., and Blasco M.A. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol. 15 (2008) 268-279
22. Sinkkonen L., Hugenschmidt T., Berninger P., Gaidatzis D., Mohn F., Artus-Revel C.G., Zavolan M., Svoboda P., and Filipowicz W. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15 (2008) 259-267
23. Lehnertz B., Ueda Y., Derijck A.A., Braunschweig U., Perez-Burgos L., Kubicek S., Chen T., Li E., Jenuwein T., and Peters A.H. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13 (2003) 1192-1200
24. Bostick M., Kim J.K., Esteve P.O., Clark A., Pradhan S., and Jacobsen S.E. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317 (2007) 1760-1764
25. Sharif J., Muto M., Takebayashi S., Suetake I., Iwamatsu A., Endo T.A., Shinga J., Mizutani-Koseki Y., Toyoda T., Okamura K., Tajima S., Mitsuya K., Okano M., and Koseki H. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450 (2007) 908-912
26. De La Fuente R., Baumann C., Fan T., Schmidtmann A., Dobrinski I., and Muegge K. Lsh is required for meiotic chromosome synapsis and retrotransposon silencing in female germ cells. Nat. Cell. Biol. 8 (2006) 1448-1454
27. Zhu H., Geiman T.M., Xi S., Jiang Q., Schmidtmann A., Chen T., Li E., and Muegge K. Lsh is involved in de novo methylation of DNA. EMBO J. 25 (2006) 335-345
28. Myant K., and Stancheva I. LSH cooperates with DNA methyltransferases to repress transcription. Mol. Cell. Biol. 28 (2008) 215-226
29. Xi S., Zhu H., Xu H., Schmidtmann A., Geiman T.M., and Muegge K. Lsh controls Hox gene silencing during development. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14366-14371
30. Wilson A.S., Power B.E., and Molloy P.L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775 (2007) 138-162
31. Okano M., Bell D.W., Haber D.A., and Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (1999) 247-257
32. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H., and Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13580-13585
33. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., and Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
34. Eden A., Gaudet F., Waghmare A., and Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300 (2003) 455
35. Lin H., Yamada Y., Nguyen S., Linhart H., Jackson-Grusby L., Meissner A., Meletis K., Lo G., and Jaenisch R. Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol. Cell. Biol. 26 (2006) 2976-2983
36. Gupta A., Godwin A.K., Vanderveer L., Lu A., and Liu J. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res. 63 (2003) 664-673
37. Jia T., Liu Y.E., Liu J., and Shi Y.E. Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res. 59 (1999) 742-747
38. Woloszynska-Read A., James S.R., Link P.A., Yu J., Odunsi K., and Karpf A.R. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. Cancer Immun. 7 (2007) 21
39. Cui H., Onyango P., Brandenburg S., Wu Y., Hsieh C.L., and Feinberg A.P. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res. 62 (2002) 6442-6446
40. Walsh C.P., Chaillet J.R., and Bestor T.H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet. 20 (1998) 116-117
41. Miki Y., Nishisho I., Horii A., Miyoshi Y., Utsunomiya J., Kinzler K.W., Vogelstein B., and Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52 (1992) 643-645
42. Howard G., Eiges R., Gaudet F., Jaenisch R., and Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 27 (2008) 404-408
43. Arai E., Kanai Y., Ushijima S., Fujimoto H., Mukai K., and Hirohashi S. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int. J. Cancer 119 (2006) 288-296
44. Peng D.F., Kanai Y., Sawada M., Ushijima S., Hiraoka N., Kitazawa S., and Hirohashi S. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis 27 (2006) 1160-1168
45. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., Cui H., Feinberg A.P., Lengauer C., Kinzler K.W., Baylin S.B., and Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416 (2002) 552-556
46. Rhee I., Jair K.W., Yen R.W., Lengauer C., Herman J.G., Kinzler K.W., Vogelstein B., Baylin S.B., and Schuebel K.E. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404 (2000) 1003-1007
47. Chen T., Hevi S., Gay F., Tsujimoto N., He T., Zhang B., Ueda Y., and Li E. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat. Genet. 39 (2007) 391-396
48. Jackson-Grusby L., Beard C., Possemato R., Tudor M., Fambrough D., Csankovszki G., Dausman J., Lee P., Wilson C., Lander E., and Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 27 (2001) 31-39
49. Egger G., Jeong S., Escobar S.G., Cortez C.C., Li T.W., Saito Y., Yoo C.B., Jones P.A., and Liang G. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 14080-14085
50. Brown K.D., and Robertson K.D. DNMT1 knockout delivers a strong blow to genome stability and cell viability. Nat. Genet. 39 (2007) 289-290
51. Beaulieu N., Morin S., Chute I.C., Robert M.F., Nguyen H., and MacLeod A.R. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J. Biol. Chem. 277 (2002) 28176-28181
52. Linhart H.G., Lin H., Yamada Y., Moran E., Steine E.J., Gokhale S., Lo G., Cantu E., Ehrich M., He T., Meissner A., and Jaenisch R. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev. 21 (2007) 3110-3122
53. Biniszkiewicz D., Gribnau J., Ramsahoye B., Gaudet F., Eggan K., Humpherys D., Mastrangelo M.A., Jun Z., Walter J., and Jaenisch R. Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol. Cell. Biol. 22 (2002) 2124-2135
54. Hernandez-Munoz I., Taghavi P., Kuijl C., Neefjes J., and van Lohuizen M. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol. Cell. Biol. 25 (2005) 11047-11058
55. Li B., Zhou J., Liu P., Hu J., Jin H., Shimono Y., Takahashi M., and Xu G. Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem. J. 405 (2007) 369-378
56. Taghavi P., and van Lohuizen M. Developmental biology: two paths to silence merge. Nature 439 (2006) 794-795
57. McGarvey K.M., Greene E., Fahrner J.A., Jenuwein T., and Baylin S.B. DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2. Cancer Res. 67 (2007) 5097-5102
58. Rajasekhar V.K., and Begemann M. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 25 (2007) 2498-2510
59. Negishi M., Saraya A., Miyagi S., Nagao K., Inagaki Y., Nishikawa M., Tajima S., Koseki H., Tsuda H., Takasaki Y., Nakauchi H., and Iwama A. Bmi1 cooperates with Dnmt1-associated protein 1 in gene silencing. Biochem. Biophys. Res. Commun. 353 (2007) 992-998
60. Kim S.H., Park J., Choi M.C., Park J.H., Kim H.P., Lee J.H., Oh D.Y., Im S.A., Bang Y.J., and Kim T.Y. DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription. Int. J. Biochem. Cell. Biol. (2008)
61. Dunican D.S., Ruzov A., Hackett J.A., and Meehan R.R. xDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function. Development 135 (2008) 1295-1302
62. Bernstein E., Duncan E.M., Masui O., Gil J., Heard E., and Allis C.D. Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol. Cell. Biol. 26 (2006) 2560-2569
63. Lyst M.J., and Stancheva I. A role for SUMO modification in transcriptional repression and activation. Biochem. Soc. Trans. 35 (2007) 1389-1392
64. Ohm J.E., and Baylin S.B. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?. Cell Cycle 6 (2007) 1040-1043
65. Fouse S.D., Shen Y., Pellegrini M., Cole S., Meissner A., Van Neste L., Jaenisch R., and Fan G. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2 (2008) 160-169
66. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., Berman D.M., Jenuwein T., Pruitt K., Sharkis S.J., Watkins D.N., Herman J.G., and Baylin S.B. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39 (2007) 237-242
67. Ehrich M., Turner J., Gibbs P., Lipton L., Giovanneti M., Cantor C., and van den Boom D. Cytosine methylation profiling of cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 4844-4849
68. Ehrlich M., Jackson K., and Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet. J. Rare Dis. 1 (2006) 2
69. Hansen R.S., Stoger R., Wijmenga C., Stanek A.M., Canfield T.K., Luo P., Matarazzo M.R., D'Esposito M., Feil R., Gimelli G., Weemaes C.M., Laird C.D., and Gartler S.M. Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. Hum. Mol. Genet. 9 (2000) 2575-2587
70. Kondo T., Bobek M.P., Kuick R., Lamb B., Zhu X., Narayan A., Bourc'his D., Viegas-Pequignot E., Ehrlich M., and Hanash S.M. Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum. Mol. Genet. 9 (2000) 597-604
71. Tao Q., Huang H., Geiman T.M., Lim C.Y., Fu L., Qiu G.H., and Robertson K.D. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum. Mol. Genet. 11 (2002) 2091-2102
72. Ueda Y., Okano M., Williams C., Chen T., Georgopoulos K., and Li E. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 133 (2006) 1183-1192
73. Gowher H., and Jeltsch A. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. J. Biol. Chem. 277 (2002) 20409-20414
74. Xie Z.H., Huang Y.N., Chen Z.X., Riggs A.D., Ding J.P., Gowher H., Jeltsch A., Sasaki H., Hata K., and Xu G.L. Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L. Hum. Mol. Genet. 15 (2006) 1375-1385
75. Jin B., Tao Q., Peng J., Soo H.M., Wu W., Ying J., Fields C.R., Delmas A.L., Liu X., Qiu J., and Robertson K.D. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum. Mol. Genet. 17 (2008) 690-709
76. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., Koseki H., Fuchikami T., Abe K., Murray H.L., Zucker J.P., Yuan B., Bell G.W., Herbolsheimer E., Hannett N.M., Sun K., Odom D.T., Otte A.P., Volkert T.L., Bartel D.P., Melton D.A., Gifford D.K., Jaenisch R., and Young R.A. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125 (2006) 301-313
77. Matarazzo M.R., Boyle S., D'Esposito M., and Bickmore W.A. Chromosome territory reorganization in a human disease with altered DNA methylation. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 16546-16551